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Objectives: The inverse relationship between QT interval variability (QTV) and T wave
amplitude potentially confounds QT variability assessment. We quantified the influence
of the T wave amplitude on QTV in a comprehensive dataset and devised a correction
formula.
Methods: Three ECG datasets of healthy subjects were analyzed to model
the relationship between T wave amplitude and QTV. To derive a generally valid
correction formula, linear regression analysis was used. The proposed correction
formula was applied to patients enrolled in the Evaluation of Defibrillator in Non-
Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE) to assess the prognostic
significance of QTV for all-cause mortality in patients with non-ischemic dilated
cardiomyopathy.
Results: A strong inverse relationship between T wave amplitude and QTV was
demonstrated, both in healthy subjects (R2 = 0.68, p < 0.001) and DEFINITE patients
(R2 = 0.20, p < 0.001). Applying the T wave amplitude correction to QTV achieved
2.5-times better group discrimination between patients enrolled in the DEFINITE study
and healthy subjects. Kaplan-Meier estimator analysis showed that T wave amplitude
corrected QTVi is inversely related to survival (p < 0.01) and a significant predictor of
all-cause mortality.
Conclusion: We have proposed a simple correction formula for improved QTV
assessment. Using this correction, predictive value of QTV for all-cause mortality in
patients with non-ischemic cardiomyopathy has been demonstrated.
Keywords: ECG, QT interval variability, T wave amplitude, risk stratification, DEFINITE
1. INTRODUCTION
Beat-to-beat fluctuations of ventricular repolarization are reflected in the QT interval variations
of surface ECG. Several studies have shown promise in exploiting QT interval variability (QTV)
for quantifying temporal repolarization lability (Baumert et al., 2016a) and associations between
elevated QTV and cardiac mortality have been reported (Berger et al., 1997; Piccirillo et al., 2007).
However, measuring the rather subtle beat-to-beat changes in QT interval remains challenging.
Novel techniques that utilize templates have been proposed and demonstrated robustness toward
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common ECG artefacts and noise (Berger et al., 1997; Starc and
Schlegel, 2006; Schmidt et al., 2014b). The relationship between
QTV and ECG artefacts (Baumert et al., 2012; Schmidt et al.,
2014b) and sampling rate (Baumert et al., 2016b) has been
investigated and recommendations have been made (Baumert
et al., 2016a). In spite of that, QTV analyses often show indifferent
results in conditions where increased repolarization variability
is anticipated (Baumert et al., 2012). A potential reason for
this discrepancy is the negative correlation between QTV and
T wave amplitude, which is particularly evident when T waves
are small and the signal-no-noise ratio is low (Baumert et al.,
2016a). Consequently, differences in the T wave amplitude across
subjects and/or ECG leads may confound statistical analyses of
QTV and impede its clinical utility (Baumert et al., 2016a).
The presented study was conducted to (1) quantify the
influence of the T wave amplitude on QTV in a comprehensive
dataset and (2) devise a correction formula to account for the
influence of T wave amplitude on QTV.
2. MATERIALS AND METHODS
2.1. Data
To assess the relationship between T wave amplitude and QTV
quantitatively and subsequently to develop a correction formula,
three ECG datasets of healthy subjects were analyzed:
Technical details for all datasets are listed in Table 1.
Athlete dataset [ATHLETE]: The dataset consists of 20
recordings from 10 healthy athletes (5 females, age: 24.8 years
[24.7 − 26.4]; 5 males, age: 26.6 years [26.5 − 28.8]); 3-lead
ECG (modified Frank lead system) (Baumert et al., 2006). ECG
were recorded during rest in the supine position for 30 min and
subsequently during standing for another 20 min. Because of
varying number of available leads (up to three leads), we used the
lead with the highest T wave amplitude (Baumert et al., 2016a)
for further analyses.
PTB Diagnostic ECG Database [PTB]: The dataset consists of
69 healthy control subjects (17 females, age: 42 ± 18 years; 52
males, age: 40±13 years) included in the Physikalisch-Technische
TABLE 1 | Descriptions and technical details of datasets used in this study.
Dataset [Abbr.] Medical
condition
Description and technical details
(Sampling rate and lead
configuration)
Athletic dataset
[ATHLETE]
20 records (20–30 min)
Healthy Athletes (lying and standing)
1600 Hz, modified 3-Lead Frank ECG
PTB Diagnostic ECG
Database [PTB]
69 records (2 min)
Healthy Healthy subjects of PTB Diagnostic
ECG Database
1000 Hz, Standard 12-Lead + 3-Lead
Frank ECG
E-HOL-12-0140-008
[TQT]
140 records (60 min)
Healthy Baseline of E-HOL-12-0140-008
– Thorough QT Study # 2
1000 Hz, 12-Lead Holter ECG
E-HOL-03-0401-017
[DEFINITE]
393 records (24 h)
Non-ischemic
cardiomyopathy
E-HOL-03-0401-017 – DEFINITE
500 Hz, 3-Lead Frank Holter ECG
Bundesanstalt (PTB) diagnostic ECG database (Bousseljot et al.,
2009). Standard 12-lead ECGs were recorded during rest for
about 2min.
Thorough QT Study dataset [TQT]: The dataset comprises
ECG of 72 healthy subjects (29 females, age: 47 ± 8 years; 43
males, age: 40±11 years) of the E-HOL-12-0140-008 dataset from
the Telemetric and Holter ECG Warehouse (THEW) repository;
60 min baseline parts (before treatment dosing) of standard
24h-Holter 12-lead ECGs were analyzed.
To investigate the efficiency of the proposed T wave
amplitude correction, we analyzed the predictive value of QTV
for all-cause mortality in patients with non-ischemic dilated
cardiomyopathy enrolled in the Evaluation of Defibrillator
in Non-Ischemic Cardiomyopathy Treatment Evaluation trial
(DEFINITE): Therefore, Holter ECG of 236 patients (67 females,
age 60 ± 14 years; 168 males, age: 58 ± 12 years; 1 not specified)
included in the E-HOL-03-0401-017 dataset [Telemetric and
Holter ECG Warehouse (THEW)] were considered. All patients
had a left ventricular ejection fraction <36% and were
randomized to receiving standard medical therapy with or
without an ICD (Kadish et al., 2004). 24h-Holter 3-lead (Frank
lead system) ECGs were performed at enrollment and after up to
5 years’ follow-up. The all-cause mortality during the follow-up
period was 4.8%. In total the dataset consists of 393 recordings.
Because of highest amplitude of T wave (Baumert et al., 2016a),
pseudo-orthogonal lead bipolar Z was used for QT interval
analysis.
2.2. QT Interval Measurement
2.2.1. ECG Pre-processing
A high pass filter (cut-off frequency 0.3 Hz) was applied to all
raw ECGs. Subsequently, QRS complexes were detected using the
algorithm described by Afonso et al. (1999) and included in the
biosig toolbox (Vidaurre et al., 2011).
2.2.2. QT Delineation
Weused two different algorithms for QTVmeasurement to verify
the T wave amplitude – QTV relationship:
(1) 2DSW
This algorithm employs a template matching technique that
relies on two-dimensional signal warping (2DSW; Schmidt et al.,
2014b). The 2DSW algorithm was shown to deliver accurate and
robust results even in noisy conditions (Zaunseder et al., 2014).
It is able to account for complex morphological changes in the
ECG waveform by adopting an averaged template beat. To track
common features of interest, e.g., the P, QRS, or QT intervals
or amplitude information, the template is annotated in a semi-
automated fashion (Laguna et al., 1994). The template adaption
is realized by superimposing a 2D mesh of warping points on
the template beat. Each warping point is shifted in time- and
amplitude-direction to minimize the Euclidean distance between
the template beat and the beat under consideration. By applying
this technique to all incoming beats, beat-to-beat changes of
common time and amplitude ECG features can be measured and
used for a comprehensive ECG variability analysis.
We applied automated beat rejection to exclude
unusable heart beats from further QTV analysis [rejection
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criterion (Schmidt et al., 2014b) was set to 10% of the median T
wave amplitude Tamp].
(2) Template stretching
The template stretching technique has been proposed by
Berger et al. to measure beat-to-beat QT interval changes (Berger
et al., 1997). The main idea is to define a template QT interval
and mark the beginning of the QRS complex and the end
of the T wave (To ensure comparable results, we used the
same annotations as in 2DSW templates). The adaption of the
template to all incoming beats is realized by linear stretching or
compressing of the template in time that it matches best. QT
interval measurement is possible with the QT template reference
and the stretching factor.
2.3. QTV Quantification
Extraction and identification of time (X) and amplitude (Y)
coordinates relating to the end of the P wave (Pend), Q wave
(Qonset), the peak of the T wave (Tpeak), and its end (Tend)
of every beat i is necessary for calculating QT interval QTi, iso-
electric level (Isolevel), and T wave amplitude Ti,amp [the Isoleveli
is defined as median value of the “flattest” waveform segment
(20 ms) between Xi,Pend and Xi,Q (Jager et al., 2003)]:
QTi = Xi,Tend − Xi,Qonset
Ti,amp = Yi,Tpeak − Isoleveli
We used the standard deviation of QT intervals (SDQT) to
quantify QTV and the median of the absolute T wave amplitude
(Tamp) to approximate T wave amplitude for a defined interval of
i = 1, 2, . . . ,N beats:
SDQT =
√
√
√
√
1
N − 1
N
∑
i=1
∣
∣QTi − QT
∣
∣
2
Tamp = median(
∣
∣Tamp
∣
∣)
2.4. Modeling of the T Wave Amplitude
– QTV Relationship
Based on previous observations (Hasan et al., 2012) a double
logarithmic model was imposed. Linear regression analyses
were conducted to specify the model parameters of the log-
transformed data:
log10(SDQT) = mc · log10(Tamp)+ nc
wheremc is the slope of the linear regression function and nc the
intercept (normalization coefficient).
To eliminate the T wave amplitude dependency of QTV,
logarithmic subtraction was used. The T wave amplitude
corrected QT interval standard deviation (cSDQT) can then be
defined as:
log10 (cSDQT) = log10 (SDQT)−mc · log10(Tamp)+ nc
cSDQT = SDQT · 10



mc·log10



T̂amp
Tamp






where T̂amp is the T wave amplitude normalization coefficient
and nc = mc · log10(T̂amp).
Accordingly, the so-called QT interval variability index
(QTVi) that was introduced by Berger et al. (1997) as a non-
invasive measure of repolarization lability was used, but utilizing
RR intervals rather than heart rates (Piccirillo et al., 2001):
QTVi = log10





SDQT2
QTmean
2
SDRR2
RRmean
2





,
where RRmean is the mean of RR time series, SDRR the standard
deviation of RR time series and QTmean the mean of QT interval
series, can be corrected for the T wave amplitude (cQTVi):
cQTVi = log10





cSDQT2
QTmean
2
SDRR2
RRmean
2





.
After some rearranging it can be rewritten as:
cQTVi = QTVi+ 2 ·mc · log10
(
T̂amp
Tamp
)
3. RESULTS
3.1. Identification of the Model Parameters
3.1.1. Comparison of Healthy Subjects
ECG data from healthy subjects were used to identify the
regression coefficient of the model. Figure 1 shows scatter plots
and regression functions of three different datasets (ATHLETE,
PTB, and TQT) of healthy subjects. Significant correlation
between SDQT and Tamp (Pearson correlation coefficient
r = 0.54, p < 0.001) and between logarithmic SDQT
(log10(SDQT)) and logarithmic T wave amplitude (log10(Tamp);
Pearson correlation coefficient r = 0.83, p < 0.001) were
observed in all healthy subjects. For detailed results see Table 2.
To obtain a general slope that is not specific to the datasets’
variations in means of SDQT and Tamp, linear regression slopes
of the three datasets of healthy subjects (ATHLETE, PTB, and
TQT) were averaged, resulting in
mc = −0.36
ms
µV
.
A T wave amplitude normalization was introduced to allow for
inter-dataset comparisons. We used the mean T wave amplitude
T̂amp, calculated by averagingTamp of all analyzed healthy records
(lead independent), resulting in:
T̂amp = 300 µV .
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FIGURE 1 | Relation between SDQT and T wave amplitude (Tamp) in datasets of healthy subjects (ATHLETE, PTB and sTQT) and DEFINITE dataset is
shown in (A). Linear regression analysis applied to logarithmized SDQT and logarithmized Tamp is plotted in (B).
3.2. Influence of QT Interval Extraction
Method
Comparing 2DSW with the template stretching algorithm shows
similar results regarding the correlation and regression between
SDQT and Tamp and between log10(SDQT) and log10(Tamp) (For
details see Table 2).
Because the standard implementation of the template
stretching method is limited to QT interval extraction and
does not provide T wave amplitude values, T wave amplitudes
extracted by 2DSW have been used for correction for the further
analysis.
3.3. Between-Lead Comparisons of the
Regression Coefficient
ECG lead dependent analysis showed similar regression slopes
(mc) for multichannel datasets: PTB: mc,PTB = −0.40 ± 0.09
[mean regression slopes of all leads where a significant relation
was found (Student’s t-test; p < 0.05)] and dataset TQT:
mc,QT = −0.33± 0.05 (12 of 12 leads, where p < 0.05).
3.4. Influence of T Wave Amplitude
Correction on QTV Assessment
3.4.1. Effect of Orthostatic Stress on QTV (ATHLETE
Dataset)
The group average of Tamp [p < 0.05 (Student’s t-test)] was
significantly higher in the supine position (398 ± 182 µV)
compared to standing (290 ± 150 µV). Conversely, SDQT was
significantly lower in the supine position compared to standing
(5.88± 2.23ms vs. 11.09± 3.70ms; p < 0.001). When correcting
for T wave amplitude, cSDQT was significantly lower while lying
compared to standing (5.88 ± 2.23 ms vs. 11.09 ± 3.70 ms;
p < 0.001). No notable differences in QTV were observed in
corrected vs. uncorrected data.
3.4.2. Predictive Value of QTV for All-Cause Mortality
in Non-ischemic Cardiomyopathy (Definite Trial)
Linear regression analysis of log10(SDQT) and log10(Tamp)
in patients with non-ischemic cardiomyopathy showed results
similar to datasets of healthy subjects, but the coefficient of
determination (R2 = 0.20) was notably smaller than in
healthy subjects. To compare QTV of healthy subjects to that
of DEFINITE patients, the TQT dataset has been used. As
QT recordings started approximately at 7 o’clock (07:08 ±
00:26 h), segments between 7 and 8 o’clock of the DEFINITE
data have been used to minimize the influence of circadian
rhythm (Schmidt et al., 2014a). Note that we could not take
into account individual differences in circadian rhythmicity (i.e.,
chronotypes) and individual activities because no time resolved
individual information on the patient state was available. A
random lead selection was applied to the TQT dataset (12-
Lead standard ECG) for comparison to the analyzed lead Z of
the DEFINITE data. We found smaller Tamp in TQT (74.35 ±
58.30 µV) compared to DEFINITE (187.18 ± 158.05 µV).
SDQT showed significant differences [p < 0.005 (Student’s
t-test)] between TQT (13.46 ± 8.81 ms) and DEFINITE
(16.73 ± 10.41 ms). Similarly, cSDQT showed highly significant
differences (TQT: 6.60 ± 2.77 ms; DEFINITE: 12.47 ± 7.36 ms;
p < 0.001). However, Cohen’s d calculated between both groups
increased 2.5-times (from 0.31 to 0.80; Figure 2).
To assess the predictive value of QTV Kaplan-Meier survival
curves were generated for trichotomized corrected QTVi
(cQTVi) values (1 – lowest tertile, 2 – medium tertile, 3– highest
tertile) of baseline Holter ECG. Results show significant
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TABLE 2 | Results of correlation and regression analysis for all datasets and QT interval extraction algorithms.
Dataset QT interval extraction algorithm Pearson correlation coefficient Linear regression slope
r mc
SDQT and Tamp log10(SDQT) and log10(Tamp) log10(SDQT) and log10(Tamp)
H
e
a
lth
y
ALL 2DSW 0.537*** 0.826*** −0.501***
Template stretching 0.246*** 0.738*** −0.454***
ATHLETE 2DSW 0.471** 0.544*** −0.427***
Template stretching 0.193 0.293* −0.270*
PTB 2DSW 0.338*** 0.598*** −0.374***
Template stretching 0.090** 0.531*** −0.393***
TQT 2DSW 0.456*** 0.584*** −0.293***
Template stretching 0.159*** 0.241*** −0.103***
DEFINITE 2DSW 0.333*** 0.449*** −0.354***
Note that data set size differs (see Table 1) and therefore quantitative comparability of correlation coefficients is limited.
*p < 0.05; **p < 0.01; ***p < 0.001;
SDQT, standard deviation of QT intervals; Tamp, median T wave amplitude.
FIGURE 2 | Boxplots of QT standard deviation SDQT (A) and corrected
QT standard deviation cSDQT (B) for healthy TQT dataset and patients
with non-ischemic cardiomyopathy (DEFINITE).
association between survival and cQTVi (p < 0.01 by the
log-rank test; Figure 3). At year one the rate of death was 0.0%
in the low and the medium cQTVi group and 5.1% in the group
with high cQTVi. After 2 years, it was 0.0% in the low cQTVi
group, 1.9% in the medium cQTVi group and 8.9% in the group
with high cQTVi. At the end of survival estimation (after 3 years)
cQTVi was 0.0 in the low cQTVi group, 1.9% in the medium
cQTVi group and 20.1% in the group with high cQTVi. We
found qualitatively similar results when using uncorrected QTVi,
but the difference in survival across tertiles was not statistically
significant (p = 0.12; Figure 3).
4. DISCUSSION
In this study we have introduced a novel T wave amplitude
correction formula for QTV analysis. Its potential for improving
QTV assessment was demonstrated by using QTV as predictor
for all-cause mortality in heart failure patients (DEFINITE; p <
0.01). Without correction, QTV prediction of all-cause mortality
is not significant (p = 0.12). At the same time, expected effects
of the sympathetic nervous system on QTV can be equally
shown even after correction (ATHLETE). Both are considered
important applications of QTV analysis (Baumert et al., 2016a).
In previous studies (Baumert et al., 2012; Hasan et al., 2012;
Schmidt et al., 2014b) as well as the current one smaller T
wave amplitudes have been shown to artificially increase QTV
owing to the noise sensitivity of common QT interval extraction
techniques. To minimize the influence of T wave amplitude,
we propose a simple correction of QTV parameters for T wave
amplitude. The correction was devised based on three datasets
of healthy subjects that were independently acquired under
different conditions, using different equipment, hence providing
a representative sample of ECG recordings. Linear regression
analyses of double log-transformed data have shown similar
behavior in all three datasets that confirm the findings of Hasan
et al. (2012). The choices of QT interval extraction algorithm
and ECG lead have not shown any major effect on the relation
between T wave amplitude and QTV.
To adjust common QTV metrics for T wave amplitude
dependency, we introduced a correction formula that yields T
wave amplitude corrected standard deviation of QT intervals
(cSDQT), offering the possibility for QTV measurement that
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FIGURE 3 | KaplanMeier survival curves; Estimated survival of DEFINITE patients for QTVi (A) and cQTVi (B; classified in tertiles: 1 – lowest tertile, 2
– medium tertile, 3 – highest tertile) for 3 years. Last observations of a patient are marked in the curves with a cross (censored data).
is less sensitive to T waveform characteristics. Furthermore, by
normalizing QTV to a specific T wave amplitude, comparisons
of QTV between leads or groups of different T wave amplitudes
become more meaningful. By adjusting the calculation of the
frequently used QTVi metric accordingly, a more precise non-
invasive measure of repolarization lability is obtained. Applying
the correction formula to QTV measurements is straight
forward; the only additional data needed is the median T wave
amplitude. In this regard, the 2DSW algorithm, for example,
offers the possibility to extract both, QT interval and T wave
amplitude.
Higher QTV has been previously reported in normal subjects
in conditions of sympathetic activation such as standing, and
hence it has been argued that high QTV is indicative of high
sympathetic tone. Given that T wave amplitude during standing
is smaller than in the supine position, previous observations
might have at least in part been the result of the inverse T
wave amplitude QTV relationship. Our results demonstrate for
the first time that the difference in QTV observed between
standing and lying is not solely caused by the reduction in T wave
amplitude.
When exploring the T wave amplitude—QTV relationship
in a clinical dataset of Holter ECG, we found a regression
coefficient similar to that of healthy subjects but a smaller R2.
Pathologic cardiac repolarization in patients with non-ischemic
cardiomyopathy might partly explain the increased variance in
the dataset. When comparing QTV between patients enrolled
in the DEFINITE study and healthy subjects, applying the
T wave amplitude correction achieves 2.5-times better group
discrimination by minimizing the inter-group variability of
T wave amplitude influence. Kaplan-Meier estimator analysis
showed that cQTVi is inversely related to survival. Patients
with non-ischemic cardiomyopathy and a high cQTVi have a
significant higher all-cause mortality than patients with low
cQTVi. Importantly, QTV was only predictive of all-cause
mortality after correcting for T wave amplitude.
Previous studies have repeatedly shown predictive value of
QTV for mortality in patients with ischemic heart disease,
where the mode of death is likely malignant ventricular
arrhythmia (Baumert et al., 2016a), but its potential for risk
stratification in patients with non-ischemic cardiomyopathy
remains to be established.
In conclusion, all ECG datasets have shown a significant
inverse relationship between T wave amplitude and QTV
of similar characteristic. Exploiting this property, a simple
correction formula has been proposed and improved QTV
assessment for predicting all-cause mortality in patients with
non-ischemic cardiomyopathy has been demonstrated.
5. LIMITATIONS
A potential limitation of the proposed correction formula is
its dependence on the algorithm that is used to delineate the
T wave. In principle, each algorithm might behave different
as a function of T wave amplitude. To account for algorithm
specific differences we did not rely on a single algorithm but
invoked two algorithms for QT extraction. Both of them were
previously shown to be very robust and appropriate for QTV
measurement (Baumert et al., 2012; Schmidt et al., 2014b). The
similar findings for both algorithm, not only qualitatively but also
quantitatively, accounts for the general usability of the proposed
correction.
Another potential limitation of the proposed algorithm is
imposed by pathophysiologic alterations of T wave amplitude.
QTV analysis is usually based on single ECG lead, representing
the scalar projection of the cardiac electric vector on a particular
point of the body surface. While in general those ECG leads are
chosen that yield high T waves (Baumert et al., 2016a), e.g., lead
II, and thereby a good signal-to-noise ratio, T wave axes may
vary between individuals and hence may represent repolarization
waves sub-optimally. This is particularly relevant in patients
with cardiac myopathies where depolarization propagation and
repolarization across the ventricular myocardium are highly
individual. Hence, the predictive value of QTVi may partly lie
in capturing differences in spatial axis-related patterns for the
QRS and T waves. The T wave amplitude correction coefficient
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introduced in this paper is agnostic to the source underlying
the T wave amplitude change. Regarding the lead which actually
has been used in this study, it should be noted that not a single
one was used, i.e., in parts differing leads have been used for
the different studies. This is mainly a consequence of our aim
to invoke as comprehensive a data set as possible. Owing to the
availability of data and the retrospective nature of our study,
we could not restrict ourselves to use the same lead. However,
extensive pretests showed that, from an algorithmic point of
view, behavior is similar across leads. Even the normalization
to a “standard” T wave amplitude, which comes along with the
proposed method, contributes to such comparability.
Finally we have to mention a limitation, which is relevant
for future studies on QTVi, normative values of QTVi and
its extended use as marker for risk stratification. Though the
primary aim of the proposed correction is to account for
the influence of T wave amplitude on QT variability metrics,
as stated before our algorithm also normalizes the resulting
QTV to a reference T wave amplitude. In principle, such
normalization is desirable, as it improves comparability of QTV
measurements between subjects and across studies. However, it
should be noted that two different definitions of QTVi exist: the
original formula relates QTV to heart rate variability (Berger
et al., 1997), while a later modification uses RR variability
instead (Piccirillo et al., 2001), and has been used in this
study. Both definitions are currently in use and the lack of
consensus adds another layer of complexity to the comparability
of QTVi measurements. Importantly, the amplitude correction
proposed in this paper is independent from the definition
of QTVi and resulted in similar improvements for either
definition (results on using HRV for normalization are not
shown).
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